cyc 202 has been researched along with nexavar in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (nexavar) | Trials (nexavar) | Recent Studies (post-2010) (nexavar) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 20 | 0 | 13 |
| Protein | Taxonomy | cyc 202 (IC50) | nexavar (IC50) |
|---|---|---|---|
| melanocortin receptor 4 | Homo sapiens (human) | 4.48 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0143 | |
| Aurora kinase B | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 other study(ies) available for cyc 202 and nexavar
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |